2018-2023 Global Depression Drugs Market Report (Status and Outlook)
- LP 2603157
- 139 Pages
- June 2018
- Medical Devices
Depression is a mental health issue. It’s a condition that starts most often in early adulthood. It’s also more common in women. However, anyone at any age may suffer from depression. Depression affects the brain, so drugs that work in the brain may offer hope. Common antidepressants may help ease your symptoms, but there are many other options as well. Each drug used to treat depression works by balancing certain chemicals in your brain called neurotransmitters. Depression Drugs is drugs used for Depression.
The classification of Depression Drugs includes SSRIs, SNRIs and others, and the proportion of SSRIs in 2016 is about 47%, and the proportion of SNRIs in 2016 is about 34%.Depression Drugs is widely used in hospitals, clinics and other places. The most proportion of Depression Drugs is hospitals, and the proportion in 2016 is 679%. The trend of hospitals is increasing.
Market competition is not intense. Intellipharmaceutics, Pfizer, Eli Lilly, Astrazeneca, Lundbeck, Allergan, GSK, Otsuka Pharmaceutical, Takeda, NHU Group, Shionogi, APOTEX, Kanghong Pharma, HUAHAI, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Over the next five years, LPI(LP Information) projects that Depression Drugs will register a 2.9% CAGR in terms of revenue, reach US$ 17300 million by 2023, from US$ 15000 million in 2017.
This report presents a comprehensive overview, market shares and growth opportunities of Depression Drugs market by product type, application, key companies and key regions.
To calculate the market size, LP Information considers value generated from the sales of the following segments:
Segmentation by product type:
SSRIs
SNRIs
Segmentation by application:
Hospitals
Clinics
Others
We can also provide the customized separate regional or country-level reports, for the following regions:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Intellipharmaceutics
Pfizer
Eli Lilly
Astrazeneca
Lundbeck
Allergan
GSK
Otsuka Pharmaceutical
Takeda
NHU Group
Shionogi
APOTEX
Kanghong Pharma
HUAHAI
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Depression Drugs market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Depression Drugs market by identifying its various subsegments.
Focuses on the key global Depression Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Depression Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Depression Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
2018-2023 Global Depression Drugs Market Report (Status and Outlook)
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Depression Drugs Market Size 2013-2023
2.1.2 Depression Drugs Market Size CAGR by Region
2.2 Depression Drugs Segment by Type
2.2.1 SSRIs
2.2.2 SNRIs
2.2.3 Others
2.3 Depression Drugs Market Size by Type
2.3.1 Global Depression Drugs Market Size Market Share by Type (2013-2018)
2.3.2 Global Depression Drugs Market Size Growth Rate by Type (2013-2018)
2.4 Depression Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Depression Drugs Market Size by Application
2.5.1 Global Depression Drugs Market Size Market Share by Application (2013-2018)
2.5.2 Global Depression Drugs Market Size Growth Rate by Application (2013-2018)
3 Global Depression Drugs by Players
3.1 Global Depression Drugs Market Size Market Share by Players
3.1.1 Global Depression Drugs Market Size by Players (2016-2018)
3.1.2 Global Depression Drugs Market Size Market Share by Players (2016-2018)
3.2 Global Depression Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Depression Drugs by Regions
4.1 Depression Drugs Market Size by Regions
4.2 Americas Depression Drugs Market Size Growth
4.3 APAC Depression Drugs Market Size Growth
4.4 Europe Depression Drugs Market Size Growth
4.5 Middle East & Africa Depression Drugs Market Size Growth
5 Americas
5.1 Americas Depression Drugs Market Size by Countries
5.2 Americas Depression Drugs Market Size by Type
5.3 Americas Depression Drugs Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Depression Drugs Market Size by Countries
6.2 APAC Depression Drugs Market Size by Type
6.3 APAC Depression Drugs Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Depression Drugs by Countries
7.2 Europe Depression Drugs Market Size by Type
7.3 Europe Depression Drugs Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Depression Drugs by Countries
8.2 Middle East & Africa Depression Drugs Market Size by Type
8.3 Middle East & Africa Depression Drugs Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Depression Drugs Market Forecast
10.1 Global Depression Drugs Market Size Forecast (2018-2023)
10.2 Global Depression Drugs Forecast by Regions
10.2.1 Global Depression Drugs Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Depression Drugs Forecast by Type
10.8 Global Depression Drugs Forecast by Application
11 Key Players Analysis
11.1 Intellipharmaceutics
11.1.1 Company Details
11.1.2 Depression Drugs Product Offered
11.1.3 Intellipharmaceutics Depression Drugs Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 Intellipharmaceutics News
11.2 Pfizer
11.2.1 Company Details
11.2.2 Depression Drugs Product Offered
11.2.3 Pfizer Depression Drugs Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 Pfizer News
11.3 Eli Lilly
11.3.1 Company Details
11.3.2 Depression Drugs Product Offered
11.3.3 Eli Lilly Depression Drugs Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Eli Lilly News
11.4 Astrazeneca
11.4.1 Company Details
11.4.2 Depression Drugs Product Offered
11.4.3 Astrazeneca Depression Drugs Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 Astrazeneca News
11.5 Lundbeck
11.5.1 Company Details
11.5.2 Depression Drugs Product Offered
11.5.3 Lundbeck Depression Drugs Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 Lundbeck News
11.6 Allergan
11.6.1 Company Details
11.6.2 Depression Drugs Product Offered
11.6.3 Allergan Depression Drugs Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 Allergan News
11.7 GSK
11.7.1 Company Details
11.7.2 Depression Drugs Product Offered
11.7.3 GSK Depression Drugs Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 GSK News
11.8 Otsuka Pharmaceutical
11.8.1 Company Details
11.8.2 Depression Drugs Product Offered
11.8.3 Otsuka Pharmaceutical Depression Drugs Revenue, Gross Margin and Market Share (2016-2018)
11.8.4 Main Business Overview
11.8.5 Otsuka Pharmaceutical News
11.9 Takeda
11.9.1 Company Details
11.9.2 Depression Drugs Product Offered
11.9.3 Takeda Depression Drugs Revenue, Gross Margin and Market Share (2016-2018)
11.9.4 Main Business Overview
11.9.5 Takeda News
11.10 NHU Group
11.10.1 Company Details
11.10.2 Depression Drugs Product Offered
11.10.3 NHU Group Depression Drugs Revenue, Gross Margin and Market Share (2016-2018)
11.10.4 Main Business Overview
11.10.5 NHU Group News
11.11 Shionogi
11.12 APOTEX
11.13 Kanghong Pharma
11.14 HUAHAI
12 Research Findings and Conclusion
Table Product Specifications of Depression Drugs
Figure Depression Drugs Report Years Considered
Figure Market Research Methodology
Figure Global Depression Drugs Market Size Growth Rate 2013-2023 ($ Millions)
Table Depression Drugs Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of SSRIs
Table Major Players of SNRIs
Table Major Players of Others
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Depression Drugs Market Size Market Share by Type (2013-2018)
Figure Global Depression Drugs Market Size Market Share by Type (2013-2018)
Figure Global SSRIs Market Size Growth Rate
Figure Global SNRIs Market Size Growth Rate
Figure Global Others Market Size Growth Rate
Figure Depression Drugs Consumed in Hospitals
Figure Global Depression Drugs Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Depression Drugs Consumed in Clinics
Figure Global Depression Drugs Market: Clinics (2013-2018) ($ Millions)
Figure Global Clinics YoY Growth ($ Millions)
Figure Depression Drugs Consumed in Others
Figure Global Depression Drugs Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Depression Drugs Market Size by Application (2013-2018) ($ Millions)
Table Global Depression Drugs Market Size Market Share by Application (2013-2018)
Figure Global Depression Drugs Market Size Market Share by Application (2013-2018)
Figure Global Depression Drugs Market Size in Hospitals Growth Rate
Figure Global Depression Drugs Market Size in Clinics Growth Rate
Figure Global Depression Drugs Market Size in Others Growth Rate
Table Global Depression Drugs Revenue by Players (2016-2018) ($ Millions)
Table Global Depression Drugs Revenue Market Share by Players (2016-2018)
Figure Global Depression Drugs Revenue Market Share by Players in 2017
Table Global Depression Drugs Key Players Head office and Products Offered
Table Depression Drugs Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Depression Drugs Market Size by Regions 2013-2018 ($ Millions)
Table Global Depression Drugs Market Size Market Share by Regions 2013-2018
Figure Global Depression Drugs Market Size Market Share by Regions 2013-2018
Figure Americas Depression Drugs Market Size 2013-2018 ($ Millions)
Figure APAC Depression Drugs Market Size 2013-2018 ($ Millions)
Figure Europe Depression Drugs Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Depression Drugs Market Size 2013-2018 ($ Millions)
Table Americas Depression Drugs Market Size by Countries (2013-2018) ($ Millions)
Table Americas Depression Drugs Market Size Market Share by Countries (2013-2018)
Figure Americas Depression Drugs Market Size Market Share by Countries in 2017
Table Americas Depression Drugs Market Size by Type (2013-2018) ($ Millions)
Table Americas Depression Drugs Market Size Market Share by Type (2013-2018)
Figure Americas Depression Drugs Market Size Market Share by Type in 2017
Table Americas Depression Drugs Market Size by Application (2013-2018) ($ Millions)
Table Americas Depression Drugs Market Size Market Share by Application (2013-2018)
Figure Americas Depression Drugs Market Size Market Share by Application in 2017
Figure United States Depression Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Canada Depression Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Depression Drugs Market Size Growth 2013-2018 ($ Millions)
Table APAC Depression Drugs Market Size by Countries (2013-2018) ($ Millions)
Table APAC Depression Drugs Market Size Market Share by Countries (2013-2018)
Figure APAC Depression Drugs Market Size Market Share by Countries in 2017
Table APAC Depression Drugs Market Size by Type (2013-2018) ($ Millions)
Table APAC Depression Drugs Market Size Market Share by Type (2013-2018)
Figure APAC Depression Drugs Market Size Market Share by Type in 2017
Table APAC Depression Drugs Market Size by Application (2013-2018) ($ Millions)
Table APAC Depression Drugs Market Size Market Share by Application (2013-2018)
Figure APAC Depression Drugs Market Size Market Share by Application in 2017
Figure China Depression Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Japan Depression Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Korea Depression Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Depression Drugs Market Size Growth 2013-2018 ($ Millions)
Figure India Depression Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Australia Depression Drugs Market Size Growth 2013-2018 ($ Millions)
Table Europe Depression Drugs Market Size by Countries (2013-2018) ($ Millions)
Table Europe Depression Drugs Market Size Market Share by Countries (2013-2018)
Figure Europe Depression Drugs Market Size Market Share by Countries in 2017
Table Europe Depression Drugs Market Size by Type (2013-2018) ($ Millions)
Table Europe Depression Drugs Market Size Market Share by Type (2013-2018)
Figure Europe Depression Drugs Market Size Market Share by Type in 2017
Table Europe Depression Drugs Market Size by Application (2013-2018) ($ Millions)
Table Europe Depression Drugs Market Size Market Share by Application (2013-2018)
Figure Europe Depression Drugs Market Size Market Share by Application in 2017
Figure Germany Depression Drugs Market Size Growth 2013-2018 ($ Millions)
Figure France Depression Drugs Market Size Growth 2013-2018 ($ Millions)
Figure UK Depression Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Italy Depression Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Russia Depression Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Spain Depression Drugs Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Depression Drugs Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Depression Drugs Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Depression Drugs Market Size Market Share by Countries in 2017
Table Middle East & Africa Depression Drugs Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Depression Drugs Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Depression Drugs Market Size Market Share by Type in 2017
Table Middle East & Africa Depression Drugs Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Depression Drugs Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Depression Drugs Market Size Market Share by Application in 2017
Figure Egypt Depression Drugs Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Depression Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Israel Depression Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Depression Drugs Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Depression Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Global Depression Drugs arket Size Forecast (2018-2023) ($ Millions)
Table Global Depression Drugs Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Depression Drugs Market Size Market Share Forecast by Regions
Figure Americas Depression Drugs Market Size 2018-2023 ($ Millions)
Figure APAC Depression Drugs Market Size 2018-2023 ($ Millions)
Figure Europe Depression Drugs Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Depression Drugs Market Size 2018-2023 ($ Millions)
Figure United States Depression Drugs Market Size 2018-2023 ($ Millions)
Figure Canada Depression Drugs Market Size 2018-2023 ($ Millions)
Figure Mexico Depression Drugs Market Size 2018-2023 ($ Millions)
Figure Brazil Depression Drugs Market Size 2018-2023 ($ Millions)
Figure China Depression Drugs Market Size 2018-2023 ($ Millions)
Figure Japan Depression Drugs Market Size 2018-2023 ($ Millions)
Figure Korea Depression Drugs Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Depression Drugs Market Size 2018-2023 ($ Millions)
Figure India Depression Drugs Market Size 2018-2023 ($ Millions)
Figure Australia Depression Drugs Market Size 2018-2023 ($ Millions)
Figure Germany Depression Drugs Market Size 2018-2023 ($ Millions)
Figure France Depression Drugs Market Size 2018-2023 ($ Millions)
Figure UK Depression Drugs Market Size 2018-2023 ($ Millions)
Figure Italy Depression Drugs Market Size 2018-2023 ($ Millions)
Figure Russia Depression Drugs Market Size 2018-2023 ($ Millions)
Figure Spain Depression Drugs Market Size 2018-2023 ($ Millions)
Figure Egypt Depression Drugs Market Size 2018-2023 ($ Millions)
Figure South Africa Depression Drugs Market Size 2018-2023 ($ Millions)
Figure Israel Depression Drugs Market Size 2018-2023 ($ Millions)
Figure Turkey Depression Drugs Market Size 2018-2023 ($ Millions)
Figure GCC Countries Depression Drugs Market Size 2018-2023 ($ Millions)
Table Global Depression Drugs Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Depression Drugs Market Size Market Share Forecast by Type (2018-2023)
Table Global Depression Drugs Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Depression Drugs Market Size Market Share Forecast by Application (2018-2023)
Table Intellipharmaceutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Intellipharmaceutics Depression Drugs Revenue and Gross Margin (2016-2018)
Figure Intellipharmaceutics Depression Drugs Market Share (2016-2018)
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Depression Drugs Revenue and Gross Margin (2016-2018)
Figure Pfizer Depression Drugs Market Share (2016-2018)
Table Eli Lilly Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eli Lilly Depression Drugs Revenue and Gross Margin (2016-2018)
Figure Eli Lilly Depression Drugs Market Share (2016-2018)
Table Astrazeneca Basic Information, Head Office, Major Market Areas and Its Competitors
Table Astrazeneca Depression Drugs Revenue and Gross Margin (2016-2018)
Figure Astrazeneca Depression Drugs Market Share (2016-2018)
Table Lundbeck Basic Information, Head Office, Major Market Areas and Its Competitors
Table Lundbeck Depression Drugs Revenue and Gross Margin (2016-2018)
Figure Lundbeck Depression Drugs Market Share (2016-2018)
Table Allergan Basic Information, Head Office, Major Market Areas and Its Competitors
Table Allergan Depression Drugs Revenue and Gross Margin (2016-2018)
Figure Allergan Depression Drugs Market Share (2016-2018)
Table GSK Basic Information, Head Office, Major Market Areas and Its Competitors
Table GSK Depression Drugs Revenue and Gross Margin (2016-2018)
Figure GSK Depression Drugs Market Share (2016-2018)
Table Otsuka Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors
Table Otsuka Pharmaceutical Depression Drugs Revenue and Gross Margin (2016-2018)
Figure Otsuka Pharmaceutical Depression Drugs Market Share (2016-2018)
Table Takeda Basic Information, Head Office, Major Market Areas and Its Competitors
Table Takeda Depression Drugs Revenue and Gross Margin (2016-2018)
Figure Takeda Depression Drugs Market Share (2016-2018)
Table NHU Group Basic Information, Head Office, Major Market Areas and Its Competitors
Table NHU Group Depression Drugs Revenue and Gross Margin (2016-2018)
Figure NHU Group Depression Drugs Market Share (2016-2018)
Table Shionogi Basic Information, Head Office, Major Market Areas and Its Competitors
Table APOTEX Basic Information, Head Office, Major Market Areas and Its Competitors
Table Kanghong Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table HUAHAI Basic Information, Head Office, Major Market Areas and Its Competitors
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
